Discontinued — last reported Q4 '25
Biogen Other Investing increased by 100.9% to $200.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $200.00K to $200.00K. Over 3 years (FY 2022 to FY 2025), Other Investing shows a downward trend with a 20.4% CAGR.
Generally neutral, but large fluctuations may indicate non-recurring events or specific financial adjustments that warrant further investigation.
This metric aggregates miscellaneous cash inflows and outflows related to investing activities that do not fit into stan...
Usually a small component of total investing cash flow; peers report similar miscellaneous items based on specific accounting treatments.
other_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$12.30M | $200.00K | -$2.20M | $0.00 | -$22.60M | $700.00K | $400.00K | $200.00K | $10.00M | $700.00K | $2.60M | $1.10M | $300.00K | $200.00K | $30.40M | -$50.80M | -$22.70M | $200.00K |
| QoQ Change | — | +101.6% | <-999% | +100.0% | — | +103.1% | -42.9% | -50.0% | >999% | -93.0% | +271.4% | -57.7% | -72.7% | -33.3% | >999% | -267.1% | +55.3% | +100.9% |
| YoY Change | — | — | — | — | -83.7% | +250.0% | +118.2% | — | +144.2% | +0.0% | +550.0% | +450.0% | -97.0% | -71.4% | >999% | <-999% | <-999% | +0.0% |